Castomize
Singapore-based medtech startup developing 4D-printed orthopedic casts and splints using heat-moldable smart materials.
- CEO / Founder
- Abel Teo
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $580K
- Latest Round
- Seed
- Key Investors
- Singapore University of Technology & Design (SUTD); VentureBlick; Co11ab; National Healthcare Group Centre for Medical Technologies & Innovations (CMTi); K-Startup Grand Challenge (grant)
Technology & Products
Key Products
Cast and Splint line (Short Arm, Long Arm, Ankle), Conversion Kit (coming soon), Prosthetics, Pet Health devices.
Technological Advantage
Proprietary 4D-printing core technology and in-house advanced manufacturing/materials formulation described as patented.
Differentiation
Value Proposition
Remouldable, breathable, waterproof orthopedic casts (branded Tessacast) that soften with heat and conform to a patient's limb, reducing discomfort versus traditional fiberglass casts.
How They Differentiate
Focus on heat-moldable, reusable 4D-printed smart materials versus single-use rigid fiberglass casts, with in-house manufacturing and clinician-informed design loop.
Market & Competition
Target Customers
Hospitals, orthopedic clinicians, physiotherapists, and veterinary health providers.
Industry Verticals
Orthopedics, physiotherapy, veterinary health
Competitors
Traditional fiberglass/plaster cast manufacturers (e.g., 3M, BSN Medical); other 3D/4D-printed orthopedic cast startups
Growth & Milestones
Growth Metrics
Reduced treatment costs by up to 25% (per VoxelMatters); regulatory clearance obtained (per VoxelMatters); secured access to a US$200M credit facility (per e27).
Major Milestones
Founded 2022; regulatory clearance for heat-molded cast; APAC Insider Singapore Business Awards 2025; MedTech Catapult collaboration (Feb 2025); 3-year company anniversary (Sep 2025).
Notable Customers
Tan Tock Seng Hospital (clinical trials); medical supply distributors in South Korea